CVS Health Corp (CVS) : Proffitt Goodson Inc scooped up 1,000 additional shares in CVS Health Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 19, 2016. The investment management firm now holds a total of 14,182 shares of CVS Health Corp which is valued at $1,438,622.CVS Health Corp makes up approximately 0.80% of Proffitt Goodson Inc’s portfolio.
CVS Health Corp opened for trading at $101.33 and hit $101.62 on the upside on Friday, eventually ending the session at $101.44, with a gain of 0.22% or 0.22 points. The heightened volatility saw the trading volume jump to 26,52,421 shares. Company has a market cap of $111,431 M.
Other Hedge Funds, Including , Randolph Co Inc added CVS to its portfolio by purchasing 159,140 company shares during the most recent quarter which is valued at $16,143,162. CVS Health Corp makes up approx 3.56% of Randolph Co Inc’s portfolio.North American Management Corp reduced its stake in CVS by selling 2,250 shares or 9.63% in the most recent quarter. The Hedge Fund company now holds 21,114 shares of CVS which is valued at $2,158,695. CVS Health Corp makes up approx 0.35% of North American Management Corp’s portfolio.Chicago Trust Co Na boosted its stake in CVS in the latest quarter, The investment management firm added 408 additional shares and now holds a total of 22,010 shares of CVS Health Corp which is valued at $2,217,948. CVS Health Corp makes up approx 0.96% of Chicago Trust Co Na’s portfolio.Triangle Securities Wealth Management reduced its stake in CVS by selling 2,710 shares or 7.69% in the most recent quarter. The Hedge Fund company now holds 32,542 shares of CVS which is valued at $3,279,257. CVS Health Corp makes up approx 2.16% of Triangle Securities Wealth Management’s portfolio.Vigilant Capital Management reduced its stake in CVS by selling 6,220 shares or 4.63% in the most recent quarter. The Hedge Fund company now holds 128,157 shares of CVS which is valued at $12,914,381. CVS Health Corp makes up approx 2.60% of Vigilant Capital Management’s portfolio.
On the company’s financial health, CVS Health Corp reported $1.53 EPS for the quarter, based on the information available during the earnings call on Feb 9, 2016. Analyst had a consensus estimate of $1.53. The company had revenue of $41145.00 million for the quarter, compared to analysts expectations of $41126.27 million. The company’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.21 EPS.
Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Shares were Reiterated by Mizuho on Feb 10, 2016 to “Buy” and Lowered the Price Target to $ 104 from a previous price target of $113 .CVS Health Corp was Initiated by Atlantic Equities to “Overweight” on Feb 3, 2016.
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.